Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 15-Sep 2021. Module: Belgian module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1932811000172118 | COVID-19 viral vector vaccine (AZD1222 (ChAdOx1-S recombinant)) of AstraZeneca, Oxford | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1932841000172119 | COVID-19 viral vector vaccine (AZD1222 (ChAdOx1-S recombinant)) of AstraZeneca, Oxford (medicinal product) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1932851000172117 | COVID-19 vaccin à vecteur viral (AZD1222 (ChAdOx1-S recombinant)) de AstraZeneca, Oxford | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1932861000172115 | COVID-19 virale vectorvaccin (AZD1222 (ChAdOx1-S recombinant)) van AstraZeneca, Oxford | nl | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| COVID-19 viral vector vaccine (AZD1222 (ChAdOx1-S recombinant)) of AstraZeneca, Oxford | Is a | COVID-19 non-replicating viral vector vaccine | true | Inferred relationship | Some | ||
| COVID-19 viral vector vaccine (AZD1222 (ChAdOx1-S recombinant)) of AstraZeneca, Oxford | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| COVID-19 viral vector vaccine (AZD1222 (ChAdOx1-S recombinant)) of AstraZeneca, Oxford | Has supplier | AstraZeneca (supplier) | true | Inferred relationship | Some | ||
| COVID-19 viral vector vaccine (AZD1222 (ChAdOx1-S recombinant)) of AstraZeneca, Oxford | Has active ingredient | Recombinant non-replicating chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (substance) | true | Inferred relationship | Some | 1 | |
| COVID-19 viral vector vaccine (AZD1222 (ChAdOx1-S recombinant)) of AstraZeneca, Oxford | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| COVID-19 viral vector vaccine (AZD1222 (ChAdOx1-S recombinant)) of AstraZeneca, Oxford | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR